Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
176.7 USD | +2.42% | +6.24% | -2.21% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.21% | 963.75Cr | |
-5.02% | 18TCr | |
+1.77% | 11TCr | |
-2.70% | 6.79TCr | |
+4.43% | 5.01TCr | |
+8.66% | 4.43TCr | |
+9.39% | 4.04TCr | |
+24.56% | 3.2TCr | |
-1.09% | 2.58TCr | |
+17.27% | 2.53TCr |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Stephens Adjusts Price Target on Repligen to $200 From $180, Maintains Overweight Rating